Biosysen Limited (HKG:1355)

Hong Kong · Delayed Price · Currency is HKD

0.1700

+0.0160 (10.39%)

Sep 11, 2026, 3:58 PM HKT

Biosysen Financials Overview

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	50.95	51.31	40.68	67.66	63	70.56
Revenue Growth	-0.70%	26.11%	-39.87%	7.40%	-10.72%	39.24%
Gross Profit	8.73	14.43	20.9	45.35	36.91	45.5
Operating Income	-33.77	-32.18	1.63	-9.26	-6.67	4.77
Net Income	-8.9	-43.53	-21.12	-38.18	-7.79	4.98
Earnings Per Share	-0.01	-0.05	-0.04	-0.09	-0.02	0.01
EPS Growth	-	-	-	-	-	141.34%

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Accommodation	24.62	29.32	39.61	67.66
Healthcare and Beauty	26.33	21.99	1.08	-
Total	50.95	51.31	40.68	67.66

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1.09	2.44	13.86	2.21	6.35	17.05
Total Debt	101.91	162.19	164.99	181.6	175.86	203.62
Net Cash (Debt)	-100.82	-159.74	-151.14	-179.38	-169.51	-186.58
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.09	-0.17	-0.27	-0.40	-0.38	-0.42

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-4.72	-32.69	24.27	35.16	9.35	30.4
Capital Expenditures	-6.78	-16.92	-0.26	-0.65	-2.94	-16.34
Free Cash Flow	-11.5	-49.61	24.01	34.51	6.41	14.06
Free Cash Flow Growth	-	-	-30.42%	438.41%	-54.41%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	17.14%	28.13%	51.38%	67.03%	58.58%	64.48%
Operating Margin	-66.29%	-62.72%	4.01%	-13.69%	-10.58%	6.77%
Pretax Margin	43.42%	-88.45%	-91.13%	-86.72%	-25.56%	-0.21%
Profit Margin	-17.47%	-84.85%	-51.91%	-56.43%	-12.37%	7.05%
FCF Margin	-22.58%	-96.69%	59.02%	51.01%	10.17%	19.92%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	-	27.48
Forward PE	-	22.40	22.40	22.40	22.40	22.40
P/FCF Ratio	-	-	4.08	2.96	16.65	9.73
PS Ratio	5.97	2.91	2.41	1.51	1.69	1.94